Sort
130,381 grants matching “hiv”
The District of Columbia Clinical Trials Unit (DC CTU)
$1,791,527Manya Magnus · George Washington University · UM1 · FY2023 · AI
Scientific Administrative Core
$1,791,513Paige L Williams · Harvard University D/B/A Harvard School Of Public Health · U19 · FY2025 · HD
Novel approaches for vaccine design
$1,791,237Michel C Nussenzweig · Rockefeller University · P01 · FY2010 · AI
Data Science Research
$1,791,117Paul M Thompson · University Of Southern California · U54 · FY2017 · EB
Expansion and targeted maturation of germline HIV-1 bNAb-associated BCRs
$1,790,906Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · P01 · FY2019 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,790,506Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2004 · AI
Targeting the PD - 1 pathway to eradicate SIV/HIV
$1,790,318Rafick-Pierre Sekaly · University Of California, San Francisco · U19 · FY2015 · AI
CFI Pathogen Inactivation of Human Plasma Units
$1,789,666Trevor P. Castor · Aphios Corporation · R44 · FY2020 · HL
Development of a Vaccine for HIVAIDS: Humoral Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Development of a Vaccine for HIVAIDS: Cellular Immunity
$1,789,624Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
HIV/AIDS Vaccine and Antibody Development
$1,789,546John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2020 · AI
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
$1,789,420Sampa Santra · Beth Israel Deaconess Medical Center · N01 · FY2016 · AI
HIV PREVENTION TRIAL UNIT
$1,788,350University Of Pennsylvania · U01 · FY2001 · AI
CENTER FOR AIDS RESEARCH(CFAR)
$1,788,256Jonathan Karn · Case Western Reserve University · P30 · FY2008 · AI
Choosing Drug Doses for Biodefense Pathogens
$1,788,209George Louis Drusano · Ordway Research Institute, Inc. · P01 · FY2007 · AI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)
$1,787,600Thomas Denny · Duke University · N01 · FY2022 · AI
Choosing Drug Doses for Biodefence Pathogens
$1,787,477George Louis Drusano · Ordway Research Institute, Inc. · P01 · FY2006 · AI
Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells
$1,787,333Carl H. June · University Of Pennsylvania · U19 · FY2011 · AI
Examining IL-15 and IL-7 as an immunotherapy agent in cancer and AIDS
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Development testing of nucleic acid-based vaccine for HIV other indications
$1,786,891Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,786,679Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
PEER TO PEER CAPACITY BUILDING OF MINISTRIES OF HEALTH IN PUBLIC SECTOR HIV PROGR
$1,786,379Lucy Slater · National Alliance/St & Terr Aids Dirctrs · U2G · FY2011 · PS
HIV Neurobehavioral Research Center
$1,786,066Robert Kernachan Heaton · University Of California, San Diego · P30 · FY2011 · MH
ADULT AIDS CLINICAL TRIALS UNIT
$1,786,066Washington University · U01 · FY2001 · AI
Community-Based VCT: Zimbabwe
$1,785,937Stephen F Morin · University Of California, San Francisco · U01 · FY2009 · MH